| Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry M Gianfrancesco, KL Hyrich, S Al-Adely, L Carmona, MI Danila, L Gossec, ... Annals of the rheumatic diseases 79 (7), 859-866, 2020 | 1222 | 2020 |
| International consensus guidance statement on the management and treatment of IgG4‐related disease A Khosroshahi, ZS Wallace, JL Crowe, T Akamizu, A Azumi, ... Arthritis & rheumatology 67 (7), 1688-1699, 2015 | 1162 | 2015 |
| The 2019 American College of Rheumatology/European league against rheumatism classification criteria for IgG4‐related disease ZS Wallace, RP Naden, S Chari, H Choi, E Della‐Torre, JF Dicaire, ... Arthritis & Rheumatology 72 (1), 7-19, 2020 | 958 | 2020 |
| Rituximab for IgG4-related disease: a prospective, open-label trial MN Carruthers, MD Topazian, A Khosroshahi, TE Witzig, ZS Wallace, ... Annals of the rheumatic diseases 74 (6), 1171-1177, 2015 | 737 | 2015 |
| Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry A Strangfeld, M Schäfer, MA Gianfrancesco, S Lawson-Tovey, JW Liew, ... Annals of the rheumatic diseases 80 (7), 930-942, 2021 | 682 | 2021 |
| IgG4‐related disease: clinical and laboratory features in one hundred twenty‐five patients ZS Wallace, V Deshpande, H Mattoo, VS Mahajan, M Kulikova, S Pillai, ... Arthritis & rheumatology 67 (9), 2466-2475, 2015 | 650 | 2015 |
| Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations ZS Wallace, H Mattoo, M Carruthers, VS Mahajan, E Della Torre, H Lee, ... Annals of the rheumatic diseases 74 (1), 190-195, 2015 | 528 | 2015 |
| Introducing the bacterial and viral bioinformatics resource center (BV-BRC): a resource combining PATRIC, IRD and ViPR RD Olson, R Assaf, T Brettin, N Conrad, C Cucinell, JJ Davis, ... Nucleic acids research 51 (D1), D678-D689, 2023 | 526 | 2023 |
| Urban built environment and depression: a multilevel analysis S Galea, J Ahern, S Rudenstine, Z Wallace, D Vlahov Journal of Epidemiology & Community Health 59 (10), 822-827, 2005 | 509 | 2005 |
| Development of a definition of postacute sequelae of SARS-CoV-2 infection T Thaweethai, SE Jolley, EW Karlson, EB Levitan, B Levy, GA McComsey, ... Jama 329 (22), 1934-1946, 2023 | 507 | 2023 |
| De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease H Mattoo, VS Mahajan, E Della-Torre, Y Sekigami, M Carruthers, ... Journal of allergy and clinical immunology 134 (3), 679-687, 2014 | 418 | 2014 |
| Clonal expansion of CD4+ cytotoxic T lymphocytes in patients with IgG4-related disease H Mattoo, VS Mahajan, T Maehara, V Deshpande, E Della-Torre, ... Journal of Allergy and Clinical Immunology 138 (3), 825-838, 2016 | 391 | 2016 |
| Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts ZS Wallace, Y Zhang, CA Perugino, R Naden, HK Choi, JH Stone Annals of the rheumatic diseases 78 (3), 406-412, 2019 | 341 | 2019 |
| Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot’ KM D’Silva, N Serling-Boyd, R Wallwork, T Hsu, X Fu, EM Gravallese, ... Annals of the rheumatic diseases 79 (9), 1156-1162, 2020 | 319 | 2020 |
| Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries MA Gianfrancesco, KL Hyrich, L Gossec, A Strangfeld, L Carmona, ... The Lancet Rheumatology 2 (5), e250-e253, 2020 | 253 | 2020 |
| Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review ZS Wallace, V Deshpande, JH Stone Seminars in arthritis and rheumatism 43 (6), 806-817, 2014 | 237 | 2014 |
| Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global Rheumatology Alliance … JA Sparks, ZS Wallace, AM Seet, MA Gianfrancesco, Z Izadi, KL Hyrich, ... Annals of the rheumatic diseases 80 (9), 1137-1146, 2021 | 234 | 2021 |
| Predictors of disease relapse in IgG4-related disease following rituximab ZS Wallace, H Mattoo, VS Mahajan, M Kulikova, L Lu, V Deshpande, ... Rheumatology 55 (6), 1000-1008, 2016 | 220 | 2016 |
| COVID-19 cases and transmission in 17 K–12 schools—Wood County, Wisconsin, August 31–November 29, 2020 A Falk MMWR. Morbidity and Mortality Weekly Report 70, 2021 | 217 | 2021 |
| IgG4-related disease and hypertrophic pachymeningitis ZS Wallace, MN Carruthers, A Khosroshahi, R Carruthers, S Shinagare, ... Medicine 92 (4), 206-216, 2013 | 213 | 2013 |
